Position in INCY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$63,688,180
+$28,852,495 QoQ
Shares Held
676,670
+91.9% QoQ
Ownership
0.339%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Gotham Asset Management, LLC holds $380,034,529 across 45 Biotechnology names. INCY ranks #2 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
82,846 | $64,010,133 | |
| 2 | INCY |
Incyte Corp
This page
|
676,670 | $63,688,180 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
746,841 | $48,268,333 | |
| 4 | EXEL |
Exelixis, Inc.
|
919,870 | $39,453,224 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
1,416,091 | $39,225,720 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
91,626 | $17,321,895 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,710 | $14,462,327 | |
| 8 | CAI |
Caris Life Sciences, Inc.
|
744,426 | $13,310,336 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,688,180 | 676,670 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,835,685 | 352,695 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,881,838 | 234,428 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,790,882 | 187,825 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,874,180 | 113,529 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,340,008 | 77,313 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,322,411 | 65,392 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,857,904 | 80,137 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $12,506,681 | 219,531 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,954,349 | 158,534 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,873,188 | 84,355 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,544,360 | 24,809 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,868,685 | 25,857 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $949,141 | 11,817 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,237,904 | 18,576 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $993,459 | 13,077 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $896,254 | 11,285 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,530,830 | 20,856 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $234,471 | 3,409 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $211,586 | 2,515 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $318,415 | 3,918 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $531,795 | 6,114 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,097,789 | 12,233 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,068,811 | 10,280 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $496,499 | 6,780 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||